PATENT CLAIM ANALYSIS

Application Number: 15877304
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "007800"]

Abstract:
An agent uses at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof as an active ingredient. The present invention also provides an agent for improving a neuropsychologic function, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof as an active ingredient. The present invention also provides an agent for changing expression of a transporter such as SLC23A2, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof, and an agent for controlling blood concentration of a cytokine such as IP-10, which contains at least one selected from the group consisting of an imidazole dipeptide and a metabolite thereof, as well as an expression analysis method for detecting improvement or degradation of a neuropsychologic function, and a kit for detecting improvement or degradation of a neuropsychologic function.

Claim (Index 8):
The method according to  claim 10 , wherein at least one kind of the imidazole dipeptide is derived from chicken.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 3.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15093207', '14656096', '15218790', '13336841', '12048510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7456684850327847
- 35 USC 102 Novelty (BERT): 0.5113336456133583
- Combined Prediction Score: 0.722235001090842
- Mean Citation Score: 150.84211999999997
- Max Citation Score: 154.53743
- Similarity Product: 80.36435177234948

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test